The Europe edge computing market is expected to reach a value of USD 1.94 Bn by 2023, expanding at a CAGR of 29.3%. Edge computing brings data processing nearer to IoT sensors to decrease latency and improve efficiency. The internet of things is driven by huge volumes of data generated...
Read MoreThe global edge computing market is forecasted to reach USD 8.96Bn by 2023, expanding at CAGR of 32.6%. Edge computing brings data processing nearer to IoT sensors, to decrease latency and improve efficiency. The internet of things are driven by huge volumes of data generated from activities in our day-to-day...
Read MoreThe cancer screening market is witnessing a rapid upsurge due to a rapid rise in the number of cancer cases. There lies an immediate need to seek early diagnosis and precautionary measures. The growth of the market lies in the adoption of innovative screening technologies to cater to the cause....
Read MoreNorth America is leading the cancer screening market. The region is technologically equipped and being a developed economy it is efficiently catering to the rising incidence of cancer cases. The market is forecasted to grow at a compound annual growth rate (CAGR) f 11.14% resulting in an annual revenue of...
Read MoreThe Middle East and Africa (MEA) cancer screening market is growing at a very slow rate. The MEA market is projected to reach USD 50.61 Bn by 2023, at a compound annual growth rate (CAGR) of 11.5% during the forecast period (2018-2023).The United Arab Emirates (UAE), Saudi Arabia and Kuwait...
Read MoreThe Latin America cancer screening market is currently valued at USD 21.24 billion and is forecasted to achieve a growth rate of 7.19 % compound annual growth rate (CAGR) leading to a regional revenue of USD 30.06 Bn. Latin Americas growth is much slower compared to other regions. The region...
Read MoreEurope after North America is the second largest market leading the cancer screening market. The market is forecasted to grow at a compound annual growth rate of (CAGR) of 8.1% resulting in an annual revenue of USD 22.43 Bn during the forecast period (2018-2023). Increase in the aging population along...
Read MoreThe United States Of America (U.S.A.) is leading the cancer screening market. The rising incidence of cancer along with growing awareness regarding prevention of diseases and diagnosis is a key driver for the market. There is increased technological advancement along with fund based initiatives towards research and development (R&D) for...
Read MoreThe United Kingdom (U.K.) stands next to the United States of America (U.S.A.) in coming up with latest technologies to combat the spread of cancer. The cancer screening market in the U.K. is expected to reach USD Bn by 2023 at a CAGR of 8.5%. Cancer screening market in the...
Read MoreChinas demand for cancer screening has grown at a fast pace in the past decade. Cancer is one of the most significant healthcare burdens in China. The Chinese economy maintains a high pace of growth stimulated by the consecutive increase in capital investment. The cancer screening market in China is...
Read More